Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
By G. Lassailly, R. Caiazzo, D. Buob, M. Pigeyre, Hélène Verkindt, J. Labreuche, V. Raverdy, E. Leteurtre, S. Dharancy, A. Louvet and 4 more. Gastroenterology, 2015
709 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery
View Paper: https://www.semanticscholar.org/paper/c6b4d739a30c475deddc671323ed38da61548c85
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
In Surgery
Citations in the corpus
- Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss (2022, background): “[78] found that bariatric and metabolic surgery results in resolution of NAFLD/NASH in the majority of the patients (64.”
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, result): “Importantly, in contrast to past data, fibrosis improved at 1 year after surgery in 33% of patients.((197)) Furthermore, a meta-analysis of available data in 2015 also showed that the majority of patients undergoing bariatric surgery appear to improve or completely resolve the histopathological feat”
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. (2019, background): “Noteworthy, worsening in fibrosis was also reported in four studies [203]. besity and nonalcoholic fatty liver disease: From pathophysiology to 16/j.metabol.2018.11.014 Regarding the specific interventions, data from head-to-head comparisons are scarce, but RYGB may be superior to AGB, similarly to ”